| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.0009 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |